Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 20, 1999

View Archived Issues

MorphoSys, CAT Both Claim Victory From Patent Ruling

Scotia Plans To Expand Studies Of Foscan In Cancer Indications

Progress In DNA Vaccines Cited At Meeting In Germany

IBT Officials See Biotechnology Regaining Favor With Investors

Icelandic Researchers Narrow Search For Pre-Eclampsia Gene

Cerep Ends ExonHit Alliance, Plans Focus On Nearer Term

Gemin X Researchers Uncover New Cancer Approach In GX011

Large Increases Expected In Australian Biotech Funding

Virtual Lab Firm Interactiva Acquired By U.S. Company

Other News To Note

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.